PI Industries reported its financial results for the quarter ended September 30, 2025, reflecting a moderation in both revenue and profit amid challenging market conditions in the agro-chemical segment.

The company posted a consolidated revenue of Rs 1,872.3 crore, down 15.7 per cent from Rs 2,221 crore during the same period last year. The decline was largely driven by the Agro-Chemical segment, which continues to account for the bulk of the company’s operations, as demand softened in certain international markets and export volumes slowed.

Net profit for Q2 stood at Rs 409.3 crore, a 19.4 per cent decline compared to Rs 508.2 crore a year ago. The dip in profit reflected lower sales volumes and a shifting product mix, though operational performance remained steady, supported by effective cost management and disciplined execution.

EBITDA performance showed resilience, with earnings of Rs 541.3 crore, down 13.8 per cent from Rs 628.4 crore last year. Margins improved slightly, rising 60 basis points to 28.9 per cent from 28.3 per cent in the prior-year period, aided by lower finance costs and a balanced approach to operating expenditure.

Segment-wise, the agro-chemical business recorded revenue of Rs 1,809 crore, down from Rs 2,179 crore a year ago, underscoring the impact of softer demand and export headwinds. In contrast, the Pharma segment continued its upward trajectory, posting revenue of Rs 63 crore, up from Rs 41 crore, highlighting the company’s diversification efforts.

The Q2 results reflect the company’s focus on resilient operational execution and strategic diversification, reinforcing its ability to maintain financial stability while responding to market volatility.